Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients
- PMID: 17340045
- DOI: 10.1007/s10067-007-0594-1
Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients
Abstract
We report two rheumatoid arthritis patients developing sarcoidosis possibly induced by etanercept. Both women, aged 46 and 53, had erosive, rheumatoid-factor-positive rheumatoid arthritis (RA) for 7 and 6 years, respectively. The eldest had received infliximab for over a year with good response, which was stopped because of a perfusion reaction. She developed a cough and dyspnea after 6 months of etanercept treatment. The other developed erythema nodosum and a plaque lesion on the right arm after 1 year of etanercept. Imaging showed, in both cases, mediastinal adenopathies. Biopsies were compatible with sarcoidosis. Etanercept withdrawal led to a complete remission. Recently, there have been reports of noninfectious granulomatous syndromes in patients receiving etanercept for a variety of diseases. In our cases, the temporal association with etanercept therapy and the complete remission after suspension of etanercept suggest a triggering role of this agent. Possible mechanisms of action and supporting evidence are discussed.
Similar articles
-
Tumor necrosis factor-alpha antagonist-induced sarcoidosis.J Clin Rheumatol. 2010 Sep;16(6):274-9. doi: 10.1097/RHU.0b013e3181efa190. J Clin Rheumatol. 2010. PMID: 20808167
-
Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.Clin Exp Rheumatol. 2008 May-Jun;26(3):471-5. Clin Exp Rheumatol. 2008. PMID: 18578973 Review.
-
Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?Clin Rheumatol. 2011 Aug;30(8):1095-8. doi: 10.1007/s10067-011-1704-7. Epub 2011 Mar 8. Clin Rheumatol. 2011. PMID: 21380931
-
Development of sarcoidosis during etanercept therapy.Intern Med. 2008;47(11):1021-5. doi: 10.2169/internalmedicine.47.0602. Epub 2008 Jun 2. Intern Med. 2008. PMID: 18520114 Review.
-
Development of pulmonary and cardiac sarcoidosis during etanercept therapy.Int J Rheum Dis. 2014 Sep;17(7):810-2. doi: 10.1111/1756-185X.12178. Epub 2013 Oct 31. Int J Rheum Dis. 2014. PMID: 24460777 No abstract available.
Cited by
-
Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2012 Nov;142(5):e1S-e111S. doi: 10.1378/chest.12-1044. Chest. 2012. PMID: 23131960 Free PMC article.
-
Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature.Clin Rheumatol. 2011 Jan;30(1):133-7. doi: 10.1007/s10067-010-1577-1. Epub 2010 Oct 1. Clin Rheumatol. 2011. PMID: 20886249
-
Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review.BMC Gastroenterol. 2021 Oct 12;21(1):373. doi: 10.1186/s12876-021-01948-6. BMC Gastroenterol. 2021. PMID: 34641810 Free PMC article. Review.
-
Translating co-stimulation blockade into clinical practice.Arthritis Res Ther. 2008;10 Suppl 1(Suppl 1):S4. doi: 10.1186/ar2415. Epub 2008 Oct 15. Arthritis Res Ther. 2008. PMID: 19007424 Free PMC article. Review.
-
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Biologics. 2008 Jun;2(2):229-52. doi: 10.2147/btt.s2210. Biologics. 2008. PMID: 19707357 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical